SCHEMBL5551399

SCHEMBL5551399

Cc1cnc(-n2cc(C(F)(F)F)cn2)nc1Oc1cccc(C(F)(F)F)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
KDM4E B2RXH2 3/20 0.47
NPSR1 Q6W5P4 3/20 0.43
MAPT P10636 3/20 0.43
KMT2A Q03164 2/20 0.43
PPP1CA P62136 1/20 0.43
LMNA P02545 1/20 0.43
MEN1 O00255 1/20 0.43
MCOLN3 Q8TDD5 1/20 0.43
F10 P00742 1/20 0.42
CYP1A2 P05177 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
ABCG2 Q9UNQ0 1/20 0.41
RECQL P46063 1/20 0.41
ADORA2A P29274 1/20 0.40
POLB P06746 2/20 0.40
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5553199 0.84 ALDH1A1 (0.35) ALDH1A1KDM4ENPSR1MAPTKMT2A
SCHEMBL7881244 0.84 ALDH1A1 (0.44) ALDH1A1KDM4ENPSR1MAPTKMT2A
SCHEMBL7873623 0.84 ALDH1A1 (0.44) ALDH1A1KDM4ENPSR1MAPTKMT2A
SCHEMBL7876395 0.81 ALDH1A1 (0.44) ALDH1A1KDM4ENPSR1MAPTKMT2A
SCHEMBL5547613 0.80 KDM4E (0.31) ALDH1A1KDM4E
SCHEMBL6182752 0.75 NPSR1 (0.55) ALDH1A1KDM4ENPSR1MAPTKMT2A
SCHEMBL8030601 0.75 ALDH1A1 (0.49) ALDH1A1KDM4ENPSR1MAPTKMT2A
SCHEMBL7005800 0.74 NPSR1 (0.53) ALDH1A1KDM4ENPSR1MAPTKMT2A
SCHEMBL7008693 0.72 CYP1A2 (0.51) ALDH1A1KDM4ENPSR1MAPTKMT2A
SCHEMBL7007726 0.72 CYP1A2 (0.51) ALDH1A1KDM4ENPSR1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7282469-B2 4-trifluoromethylpyrazolyl-substituted pyridines and pyrimidines BAYER CROPSCIENCE GMBH (DE) 2007-10-16 US disclosed
EP-1527067-B1 4-TRIFLUOROMETHYLPYRAZOLYL SUBSTITUTED PYRIDINES AND PYRIMIDINES BAYER CROPSCIENCE GMBH (DE) 2006-10-04 EP disclosed
EP-1527067-A1 4-TRIFLUOROMETHYLPYRAZOLYL SUBSTITUTED PYRIDINES AND PYRIMIDINES Bayer CropScience GmbH (DE) 2005-05-04 EP disclosed
US-20040082475-A1 4-trifluoromethylpyrazolyl-substituted pyridines and pyrimidines BAYER CROPSCIENCE AG (DE) 2004-04-29 US disclosed
WO-2004013129-A1 4-TRIFLUOROMETHYLPYRAZOLYL SUBSTITUTED PYRIDINES AND PYRIMIDINES BAYER CROPSCIENCE GMBH (DE) 2004-02-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040082475-A1 4-trifluoromethylpyrazolyl-substituted pyridines and pyrimidines NOX4, CYP4X1, ROS1 ALDH1A1 394/4885KDM4E 1306/4885NPSR1 1703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.